Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 31170161.
- Also identified by DOI 10.1371/journal.pmed.1002824 and PMC identifier 6553715.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In a Perspective for the Tuberculosis Special Issue, Kevin Schwartzman and colleagues discuss the choices and implications for personal versus public health benefits when pursuing tuberculosis elimination in low-incidence countries.
Medical subject headings
- Antitubercular Agents
- Health Policy
- Latent Tuberculosis